Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Change in Accured Expenses (2018 - 2025)

TELA Bio (TELA) has 8 years of Change in Accured Expenses data on record, last reported at $633000.0 in Q3 2025.

  • For Q3 2025, Change in Accured Expenses fell 61.87% year-over-year to $633000.0; the TTM value through Sep 2025 reached $255000.0, down 86.12%, while the annual FY2024 figure was -$1.8 million, 143.31% down from the prior year.
  • Change in Accured Expenses reached $633000.0 in Q3 2025 per TELA's latest filing, down from $1.4 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $2.8 million in Q4 2023 and bottomed at -$3.5 million in Q1 2024.
  • Average Change in Accured Expenses over 5 years is $449315.8, with a median of $1.0 million recorded in 2021.
  • Peak YoY movement for Change in Accured Expenses: skyrocketed 1136.53% in 2021, then tumbled 130.03% in 2024.
  • A 5-year view of Change in Accured Expenses shows it stood at $1.1 million in 2021, then soared by 43.88% to $1.6 million in 2022, then surged by 75.25% to $2.8 million in 2023, then crashed by 130.03% to -$842000.0 in 2024, then soared by 175.18% to $633000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Accured Expenses were $633000.0 in Q3 2025, $1.4 million in Q2 2025, and -$930000.0 in Q1 2025.